The L76V mutation in HIV-1 protease is potentially associated with hypersusceptibility to protease inhibitors Atazanavir and Saquinavir is there a clinical advantage 英文参考文献.docVIP

下载本文档

1
0
约3.57万字
约 9页
2017-05-13 发布于上海
举报

The L76V mutation in HIV-1 protease is potentially associated with hypersusceptibility to protease inhibitors Atazanavir and Saquinavir is there a clinical advantage 英文参考文献.doc

The L76V mutation in HIV-1 protease is potentially associated with hypersusceptibility to protease inhibitors Atazanavir and Saquinavir is there a clinical advantage 英文参考文献

Wiesmannetal.AIDSResearchandTherapy2011,8:7 /content/8/1/7 SHORT REPORT OpenAccess TheL76VmutationinHIV-1proteaseispotentially associatedwithhypersusceptibilitytoprotease inhibitorsAtazanavirandSaquinavir:istherea clinicaladvantage? FrankWiesmann1*,JanVachta1,RobertEhret1,HaukeWalter2,RolfKaiser3,MartinStürmer4,AndréTappe5, MartinD?umer6,ThomasBerg7,GudrunNaeth1,PatrickBraun1,HeribertKnechten1 Abstract Background:AlthoughbeingconsideredasararelyobservedHIV-1proteasemutationinclinicalisolates,the L76V-prevalenceincreased1998-2008insomeEuropeancountriesmostlikelyduetotheapprovalofLopinavir, Am

您可能关注的文档

文档评论（0）

1亿VIP精品文档

更多 >

The L76V mutation in HIV-1 protease is potentially associated with hypersusceptibility to protease inhibitors Atazanavir and Saquinavir is there a clinical advantage 英文参考文献.docVIP